APA (7th ed.) Citation

PC, P., MA, Y., RBV, M., FM, M., AL, B., JCB, d. M., . . . VF, A. (2026). Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases. Advances in rheumatology (London, England), 66(1), . https://doi.org/10.1186/s42358-026-00523-5

Chicago Style (17th ed.) Citation

PC, Pereira, et al. "Position Statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the Interchangeability of Originator and Biosimilar Biologics in Immune-mediated Rheumatic Diseases." Advances in Rheumatology (London, England) 66, no. 1 (2026). https://doi.org/10.1186/s42358-026-00523-5.

MLA (9th ed.) Citation

PC, Pereira, et al. "Position Statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the Interchangeability of Originator and Biosimilar Biologics in Immune-mediated Rheumatic Diseases." Advances in Rheumatology (London, England), vol. 66, no. 1, 2026, https://doi.org/10.1186/s42358-026-00523-5.